Follicular Lymphoma Clinical Trials

There are 11 registered clinical trials for Follicular Lymphoma in the TrialLens index.

Trials (11)

• A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma Phase 3 · The Lymphoma Academic Research Organisation
• Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma Phase 3 · SecuraBio
• Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma Phase 2 · The First Affiliated Hospital of Xiamen University
• Personalized Risk Stratification Model of Follicular Lymphoma Patients N/A · Oncology Institute of Southern Switzerland
• A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers Phase 1 · Eli Lilly and Company
• Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma Phase 2 · Fondazione Italiana Linfomi - ETS
• Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia Phase 1 · TG Therapeutics, Inc.
• Tazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma Phase 2 · Weill Medical College of Cornell University
• Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma Phase 1/2 · PersonGen BioTherapeutics (Suzhou) Co., Ltd.
• Double Cord Versus Haploidentical (BMT CTN 1101) Phase 3 · Medical College of Wisconsin
• Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma Phase 3 · Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Related landscapes

• Phase 1/2 Follicular Lymphoma
• Phase 2 Follicular Lymphoma
• Phase 3 Follicular Lymphoma
• N/A Follicular Lymphoma
• Phase 1 Follicular Lymphoma

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.